(This note is not part of the Regulations)
These Regulations further amend the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980 by amending regulation 8 of those Regulations (pack size on retail sale or supply of certain medicinal products on a general sale list) to—
(a)increase the maximum pack size of non-effervescent enteric-coated tablets containing low dose aspirin, up to 75 mg, on the general sale list which may be sold or supplied from outlets other than registered pharmacies from 16 tablets to 28;
(b)provide that liquid preparations containing ibuprofen which are on the general sale list may be sold or supplied from outlets other than registered pharmacies where the packaging or container of the product contains individual unit doses of the product to a maximum of 20 doses, of not more than 5 millilitres each;
(c)provide that medicinal products which contain cetirizine hydrochloride and which are on the general sale list may be sold or supplied from outlets other than registered pharmacies in containers or packaging containing not more than 7 tablets, that products which contain loratadine may be sold or supplied in the same circumstances in containers or packaging containing not more than 7 tablets, and that products which contain ibuprofen lysine may be sold or supplied in the same circumstances in containers or packaging containing not more than 16 tablets.
An assessment of the cost to business of complying with these Regulations has been made, copies of which have been placed in the libraries of both Houses of Parliament. Further copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10-202, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.